The evolution of stereo-electroencephalography (SEEG) has transformed epilepsy treatment by offering deeper insights into seizure foci localization and seizure networks.
Advancements in SEEG Technology: Enhancing Epilepsy Treatment

The evolution of stereo-electroencephalography (SEEG) has transformed epilepsy treatment by offering deeper insights into seizure foci localization and seizure networks. As technology advances, recent breakthroughs continue to refine SEEG’s role in evaluating and managing drug-resistant epilepsy. These developments not only enhance clinical decision-making but also improve patient outcomes by guiding more precise surgical interventions.
Breakthroughs in SEEG Technology
In recent years, several advancements have emerged that contribute to the growing precision of SEEG:
- Integration with Advanced Imaging Modalities: Studies show that combining SEEG with imaging techniques such as MRI, FDG-PET, and MEG strengthens the localization of epileptogenic zones (EZs) (Grinenko et al., 2018)(Satzer et al., 2022)(Sukprakun, Tepmongkol, 2022). By using multimodal approaches, clinicians gain a more comprehensive understanding of seizure networks, leading to better surgical outcomes.
- High-Frequency Oscillations (HFOs) as Predictors of Seizure Onset: Research highlights the importance of fast ripples (250-500 Hz) and their role in identifying epileptogenic tissue. While traditional biomarkers like spikes and standard EEG readings have limitations in specificity, fast ripples have emerged as more reliable predictors of surgical success (Fabbri et al., 2025)(Schonberger et al., 2019).
- Interictal Biomarkers for SEEG-Guided Surgery: The co-occurrence of spikes and ripples (S+R) within SEEG recordings has demonstrated superior predictive accuracy in delineating the epileptogenic zone compared to spikes and ripples detected separately. (Fabbri et al., 2025). This has significant implications for refining surgical targeting and reducing unnecessary resections.|
- Machine Learning for Epileptic Zone Identification: Advances in computational analysis are revolutionizing SEEG interpretation. Recent research has explored how artificial intelligence and machine learning models, trained on SEEG data, can improve epileptogenic zone identification. These models analyze spectral features of seizures and improve differentiation between primary seizure-generating areas and propagation zones (Grinenko et al., 2018).
These developments reinforce SEEG’s role as an indispensable tool for epilepsy surgery planning, ensuring that interventions are based on strong data rather than broad estimations.
The Role of SEEG in Modern Epilepsy Treatment
SEEG remains the gold standard for mapping seizure networks in patients with drug-resistant epilepsy. Unlike surface EEG, which is limited to cortical activity, SEEG provides three-dimensional depth recordings, allowing clinicians to:
- Pinpoint epileptogenic foci with high precision
- Differentiate between primary and propagated seizure activity
- Precisely map the brain to prepare for resection with the aim to preserve eloquent brain regions while maximizing seizure-free outcomes
Recent findings emphasize the role of fast gamma activity in identifying the epileptogenic zone. Studies indicate that a fingerprint of epileptogenic activity consists of sharp transients, high-frequency oscillations, and a suppression of lower frequencies at seizure onset (Grinenko et al., 2018). Recognizing these patterns in SEEG recordings allows for a more targeted surgical approach, minimizing unnecessary resections.
Looking Ahead: The Future of SEEG
The ongoing refinement of SEEG technology and its integration with AI-driven analytics, interictal biomarkers, and multimodal imaging are paving the way for a new era in epilepsy surgery. Future directions include:
- Real-time seizure prediction models using SEEG data to enable proactive interventions
- Personalized treatment plans based on biomarker-driven precision medicine
- Advances in minimally invasive SEEG electrode designs to improve patient safety and comfort
For medical professionals, staying updated on these advancements is crucial for optimizing treatment strategies. As the field of epilepsy surgery continues to evolve, SEEG remains at the forefront of innovation, driving better outcomes for patients worldwide.
Stay informed about the latest SEEG advancements, subscribe to DIXI medical Dispatch for expert insights and updates on epilepsy treatment strategies.
The global leader for SEEG depth electrodes, resuming direct sales in the U.S. following the contractual end of its distribution partnership with NeuroPace.
Epilepsy treatment has come a long way. For decades, clinicians relied on surface EEG and educated guesswork to determine the origins of seizures, often falling short when it came to localizing deep-seated seizure foci.
Neurosurgery is experiencing a transformative era, with intracerebral electrodes playing a pivotal role in advancing our understanding and treatment of neurological disorders, particularly epilepsy.
Faiçal Isbaine joined DIXI medical as our new Director Clinical Development
We are pleased to announce the creation of a new scientific direction within DIXI medical...
At DIXI medical, we are proud to support the continuing and specialized education of healthcare professionals in the field of epilepsy.
We are delighted to announce the arrival of our new VP Research & Development, Pierre Fridez.
We are thrilled to announce that Health Canada has approved thermocoagulation procedures as an extension of the intended use of our depth electrodes.
John Gale, renowned Neurophysiologist, Vice President of DIXI NeuroLab, launches an insightful 6-Episode webinar on the inner workings of the human brain and microelectrode recordings.
MEET KILLIAN PEIER! Killian Peier is a Swiss ski-jumping athlete, silver medallist at the World Championships in 2018. DIXI is proud to
PASSION AND DEDICATION In those uncertain times, some things remain unchanged… our passion and dedication!It might be ski jumping, or manufacturing intracerebral
A BIT OF FRESH AIR… We all love Summertime! ? But we also do like to have a short and refreshing break
EPILEPSYX.NET DIXI medical is very proud to support EpilepsyX.Net. This initiative is made by and for Doctors and Healthcare Professional Treating Epilepsy Care
NEW MEMS SEEG ELECTRODE Exciting news for the future of SEEG electrodes! Click on the link here: https://www.globenewswire.com/news-release/2021/07/06/2257955/0/en/Adept-Neuro-Reaches-Key-Milestone-in-the-Development-of-Novel-Intracerebral-Stereoelectroencephalography-SEEG-Electrodes.html Video template title Video
KILLIAN IS BACK IN THE AIR? Killian did his first jump since his injury! We are delighted to know him back in
EPILEPSY AWARENESS MONTH? November is Epilepsy Awareness Month. It is time to exchange, share information, and raise awareness together. Video template title Video
MICRODEEP® MICRO-MACRO DEPTH ELECTRODE We are very happy to announce that the MICRODEEP® Micro-Macro Electrode is now FDA cleared. A unique multi-contact, flexi-rigid
NEUROPACE ANNOUNCES DISTRIBUTION AGREEMENT WITH DIXI MEDICAL USA NeuroPace Announces Distribution Agreement with DIXI Medical USA, Provider of Intracranial Electrodes and Instruments